Towards infertility care on equal terms: a prime time for male infertility.
Assisted reproductive technology
Male infertility
Male reproductive health
Management
Quality of life
Semen analysis
Journal
Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
received:
07
02
2023
revised:
21
03
2023
accepted:
03
04
2023
medline:
3
7
2023
pubmed:
19
5
2023
entrez:
18
5
2023
Statut:
ppublish
Résumé
Male infertility is a disease that deserves greater clinical attention and research. A universally accepted definition that emphasizes the modulatory impact of age, lifestyle and environmental factors and includes comprehensive diagnostic and treatment guidelines is needed to ensure accurate evaluation and effective care. Accordingly, male infertility should be defined as a disease of the male reproductive system, caused primarily by congenital and genetic conditions, anatomical, endocrine, functional or immunological abnormalities of the reproductive system, genital tract infections, cancer and its related treatments, and sexual disorders incompatible with intercourse. Inadequate lifestyle, exposure to toxicants and advanced paternal age are critical factors acting alone or exacerbating the impact of known causative factors. The focus on male infertility must be balanced with that on female infertility to ensure the best possible outcome for the couple. Fertility clinics are encouraged to prioritize collaboration with reproductive urologists and andrologists to provide the best possible care for male infertility patients.
Identifiants
pubmed: 37202319
pii: S1472-6483(23)00212-2
doi: 10.1016/j.rbmo.2023.04.003
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
11-14Informations de copyright
Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.